March 29, 2017
Alliance Pharma’s profit up to €20M
Alliance Pharma, the specialty pharmaceutical company, has announced results for the year ended 31 December 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Alliance Pharma, the specialty pharmaceutical company, has announced results for the year ended 31 December 2016.
Alliance Pharma’s revenue for 2016, driven by the acquisition of ex-Sinclair products in December 2015, could be more than double compared to the previous year.
Sinclair IS Pharma plc will sell its non-aesthetics business to Alliance Pharma plc for £132m